Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Why do so many seniors with memory loss and dementia never get tested?

  • 'Off switch' for pain discovered: Activating the adenosine A3 receptor subtype is key to powerful pain relief

  • Full-day preschool linked with increased school readiness compared with part-day

  • Diagnosing deafness early will help teenagers' reading development

  • Why do people with autism see faces differently?

  • Sportswomen still second best to sportsmen, in the press

  • Inpatient psychotherapy is effective in Germany

  • How various brain areas interact in decisions

  • Pleasure at another's misfortune is evident in children as young as two

  • Isolation of important centres in brain results in age-related memory deficits

  •